Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
7,635
+52
+0.7% +$7.88K 0.68% 50
2026
Q1
$1.1M Buy
7,583
+612
+9% +$97.5K 0.76% 51
2025
Q4
$1.12M Buy
6,971
+1,301
+23% +$213K 0.75% 49
2025
Q3
$880K Buy
5,670
+1,305
+30% +$201K 0.64% 61
2025
Q2
$664K Buy
4,365
+608
+16% +$86.9K 0.58% 59
2025
Q1
$552K Sell
3,757
-2,648
-41% -$389K 0.57% 55
2024
Q4
$862K Buy
6,405
+1,145
+22% +$150K 0.46% 62
2024
Q3
$719K Sell
5,260
-1,987
-27% -$243K 0.44% 62
2024
Q2
$741K Buy
7,247
+2
+0% +$195 0.52% 50
2024
Q1
$643K Buy
7,245
+330
+5% +$27.4K 0.48% 41
2023
Q4
$626K Buy
6,915
+1,320
+24% +$106K 0.53% 37
2023
Q3
$438K Buy
+5,595
New +$480K 0.4% 48

Other funds holding MMM

BluePath Capital Management's MMM Position: Q2 2026 in Review

BluePath Capital Management increased its 3M (MMM) stake by 0.69% in Q2 2026, buying an estimated $7.88K and bringing the position to 7,635 shares worth $1.24M. The position accounts for 0.68% of the portfolio, ranked #50.

BluePath Capital Management first reported a position in MMM in Q3 2023 and has held it in 12 quarters since. 683 funds tracked by Wall St. Rank hold MMM as of Q2 2026.

  • BluePath Capital Management held 7,635 shares of 3M worth $1.24M as of Q2 2026.
  • BluePath Capital Management bought 52 3M shares in Q2 2026, an estimated $7.88K.
  • 3M made up 0.68% of BluePath Capital Management's portfolio in Q2 2026, its #50 holding.
  • BluePath Capital Management first reported a position in 3M in Q3 2023 and has held it in 12 quarters since.
  • 683 funds tracked by Wall St. Rank held 3M as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.